Study of Maintenance of the Efficiency and Adverse Effects of Pharmacological Treatments in Sex Offenders With Paraphilia

NANot yet recruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

October 31, 2027

Conditions
Paraphilia
Interventions
BEHAVIORAL

Evaluation Scales

"* PATHOS / PEACCE : hypersexuality diagnostic scale~* PDQ-4+: Personality Diagnostic Questionnaire version 4~* AUDIT~* Life trajectory : THQ~* Cognitive function (MoCA, Stroop)~* ISDSS: and self report of sexual activity and desire~* BARS: Brief Adhesion Rating Scale (treatment observance)~* SF-36 scale : quality of life~* BDI-II : Beck Depression Inventory~* BSSI ; Beck suicidal Inventory~* Cognitive functioning evaluation : Molest and Rape Scale~* Empathy: EMPAT~* Evaluation of Cognitive functioning: denial evaluation and Mc Kibben minimization~* Baratt Impulsivity Scale~* CSBI~* Static 99 and Stable 2007"

OTHER

osteodensitometry

Osteodensitometry

BIOLOGICAL

blood samples

"* Lipid profile (total cholesterol, triglycerides, HDL cholesterol)~* Liver function (ASAT, ALAT, total bilirubin, transferase gamma-glutamyl et alcalin phosphatases~* Kydney function~* Blood count~* Biological Measurements and Measurement of Systematic Plasma Testosterone and TeBG Levels in Sex Offenders check for pathology of the Gonadotropin Axis~* Biological Measurements of Plasma Prolactin level"

OTHER

ECG

ECG (heart rate, search for cardiac conduction disorders or cardiac arrhythmias)

GENETIC

Blood and saliva samples

Blood and saliva samples

Trial Locations (1)

75014

Hôpital Cochin, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04316650 - Study of Maintenance of the Efficiency and Adverse Effects of Pharmacological Treatments in Sex Offenders With Paraphilia | Biotech Hunter | Biotech Hunter